We are monitoring the impact of COVID-19 on Atipamezole Market Get in touch with us for detailed analysis Know More
Pulished Date August, 2019
ID: 6473
Share on
Share on

Atipamezole Market Analysis – By Application (Anti-sedatives, Others), Route of Administration (Intramuscular, Intravenous, Subcutaneous, Intraperitoneal) & Region – Global Industry Size, Share, Trends, Forecast & Growth | 2019 – 2024

Pulished: August, 2019
ID: 6473
Pages: 175

Atipamezole Market Size & Growth (2019 – 2024)

According to the report, the Size of the Atipamezole Market was valued at USD xx Billion in 2019 and is expected to reach USD xx Billion by 2024, to grow at a CAGR of xx% during the forecast period 2019-2024.

Atipamezole is an α2 adrenergic receptor antagonist which is synthetic, suggested for the reversal of analgesic and sedative effects of medetomidine and dexmedetomidine in dogs. It has been researched in humans as well as a potential drug for Parkinson’s disease.

Atipamezole reverses the effects of analgesic and sedative drugs like xylazine, medetomidine, detomidine, and amitraz among others in animals. Also, in addition, it is used in treating imidazoline and amitraz decongestants toxicity among animals.

The decrease in sedative time of animals decreases the stay in-clinic, decreases hospitalization costs, reduces animal owners revisits and optimizes the time of staff. Also, increasing healthcare expenditure on animals and growing pet ownership is expected to propel the market growth. However, the market is constrained due to factors such as and stringent government regulations associated with the efficacy and safety of atipamezole and adverse effects of atipamezole among others.

REPORT COVERAGE

REPORT METRIC

DETAILS

Market Size Available

2018 – 2024

Base Year

2018

Forecast Period

2019 – 2024

Segments Analysed

By Application, Route of Administration, and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Analysed

North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Companies Analysed

Pfizer Inc., Orion Corporation, Alvetra & Werfft GmbH, CP Pharmaceuticals Ltd., Sogeval Laboratories, Inc., VetPharm, Inc., Ceva Sant Animale S.A., Dr. E. Graeub AG, A x ience SAS and Eli Lilly

 

This research report on the Global Atipamezole Market has been segmented and sub-segmented into the following categories and calculated market size and forecast for each segment until 2024.

Atipamezole Market - By Application

  • Anti-sedatives
  • Others

Atipamezole Market - By Route of Administration

  • Intramuscular
  • Intravenous
  • Subcutaneous
  • Intraperitoneal

Regional Analysis

North America has the leading market for Atipamezole in the world, which is followed by Europe and Asia Pacific regions. Asia Pacific region is expected to have the fastest growth rate during the forecast period, owing to the growing population bases in the region.

Promising Companies leading the Global Atipamezole Market Profiled in the Report are

  1. Pfizer Inc
  2. Orion Corporation
  3. Alvetra & Werfft GmbH
  4. CP Pharmaceuticals Ltd
  5. Sogeval Laboratories, Inc
  6. VetPharm, Inc
  7. Ceva Sant Animale S.A
  8. Dr. E. Graeub AG
  9. A x ience SAS
  10. Eli Lilly

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemiology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Application                 

                                5.1.1 Anti-Sedatives       

                                5.1.2 Others      

                                5.1.3  Y-o-Y Growth Analysis, By Application        

                                5.1.4  Market Attractiveness Analysis, By Application      

                                5.1.5  Market Share Analysis, By Application       

                5.2 Route of Administration                       

                                5.2.1 Intramuscular        

                                5.2.2 Intravenous            

                                5.2.3 Subcutaneous       

                                5.2.4 Intraperitoneal      

                                5.2.5 Y-o-Y Growth Analysis, By Route of Administration               

                                5.2.6 Market Attractiveness Analysis, By Route of Administration             

                                5.2.7 Market Share Analysis, By Route of Administration              

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Application

                                                6.1.3.2 By Route of Administration

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.3.1 By Application

                                                6.1.3.2 By Route of Administration

                                6.1.5  Market Share Analysis      

                                                6.1.3.1 By Application

                                                6.1.3.2 By Route of Administration

                6.2 North America                          

                                6.2.1 Introduction           

                                6.2.2 United States         

                                6.2.3 Canada     

                6.3 Europe                         

                                6.3.1 Introduction           

                                6.3.2 U.K             

                                6.3.3 Spain         

                                6.3.4 Germany 

                                6.3.5 Italy            

                                6.3.6 France       

                6.4 Asia-Pacific                 

                                6.4.1 Introduction           

                                6.4.2 China         

                                6.4.3 India          

                                6.4.4 Japan         

                                6.4.5 Australia   

                                6.4.6 South Korea           

                6.5 Latin America                             

                                6.5.1 Introduction           

                                6.5.2 Brazil          

                                6.5.3 Argentina

                                6.5.4 Mexico     

                                6.5.5 Rest of Latin America          

                6.6 Middle East & Africa                               

                                6.6.1 Introduction           

                                6.6.2 Middle-East            

                                6.6.3 Africa         

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Pfizer Inc.                    

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Orion Corporation                   

                8.3 Alvetra & Werfft GmbH                        

                8.4 CP Pharmaceuticals Ltd.                        

                8.5 Sogeval Laboratories, Inc.                    

                8.6 VetPharm, Inc.                          

                8.7 Ceva Sant Animale S.A.                         

                8.8 Dr. E. Graeub AG                      

                8.9 A x ience SAS                             

                8.10 Eli Lilly and Company                            

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, Collaborations, and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Global and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • The segment-level analysis in terms of market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Global Atipamezole  Market By Region, From 2019-2024 ( USD Billion )
  2. Global Atipamezole  Market By Application, From 2019-2024 ( USD Billion )
  3. Global Anti-Sedatives  Market By Region, From 2019-2024 ( USD Billion )
  4. Global Others Market By Region, From 2019-2024 ( USD Billion )
  5. Global Atipamezole  Market By Route of Administration , From 2019-2024 ( USD Billion )
  6. Global Intramuscular Market By Region, From 2019-2024 ( USD Billion )
  7. Global Intravenous Market By Region, From 2019-2024 ( USD Billion )
  8. Global Subcutaneous  Market By Region, From 2019-2024 ( USD Billion )
  9. Global Intraperitoneal Market By Region, From 2019-2024 ( USD Billion )
  10. North America Atipamezole  Market By Application, From 2019-2024 ( USD Billion )
  11. North America Anti-Sedatives  Market By Region, From 2019-2024 ( USD Billion )
  12. North America Others Market By Region, From 2019-2024 ( USD Billion )
  13. North America Atipamezole  Market By Route of Administration , From 2019-2024 ( USD Billion )
  14. North America Intramuscular Market By Region, From 2019-2024 ( USD Billion )
  15. North America Intravenous Market By Region, From 2019-2024 ( USD Billion )
  16. North America Subcutaneous  Market By Region, From 2019-2024 ( USD Billion )
  17. North America Intraperitoneal Market By Region, From 2019-2024 ( USD Billion )
  18. United States Atipamezole  Market By Application, From 2019-2024 ( USD Billion )
  19. United States Atipamezole  Market By Route of Administration , From 2019-2024 ( USD Billion )
  20. Canada Atipamezole  Market By Application, From 2019-2024 ( USD Billion )
  21. Canada Atipamezole  Market By Route of Administration , From 2019-2024 ( USD Billion )
  22. Europe Atipamezole  Market By Application, From 2019-2024 ( USD Billion )
  23. Europe Anti-Sedatives  Market By Region, From 2019-2024 ( USD Billion )
  24. Europe Others Market By Region, From 2019-2024 ( USD Billion )
  25. Europe Atipamezole  Market By Route of Administration , From 2019-2024 ( USD Billion )
  26. Europe Intramuscular Market By Region, From 2019-2024 ( USD Billion )
  27. Europe Intravenous Market By Region, From 2019-2024 ( USD Billion )
  28. Europe Subcutaneous  Market By Region, From 2019-2024 ( USD Billion )
  29. Europe Intraperitoneal Market By Region, From 2019-2024 ( USD Billion )
  30. U.K. Atipamezole  Market By Application, From 2019-2024 ( USD Billion )
  31. U.K. Atipamezole  Market By Route of Administration , From 2019-2024 ( USD Billion )
  32. Germany Atipamezole  Market By Application, From 2019-2024 ( USD Billion )
  33. Germany Atipamezole  Market By Route of Administration , From 2019-2024 ( USD Billion )
  34. France Atipamezole  Market By Application, From 2019-2024 ( USD Billion )
  35. France Atipamezole  Market By Route of Administration , From 2019-2024 ( USD Billion )
  36. Italy Atipamezole  Market By Application, From 2019-2024 ( USD Billion )
  37. Italy Atipamezole  Market By Route of Administration , From 2019-2024 ( USD Billion )
  38. Spain Atipamezole  Market By Application, From 2019-2024 ( USD Billion )
  39. Spain Atipamezole  Market By Route of Administration , From 2019-2024 ( USD Billion )
  40. Asia Pacific Atipamezole  Market By Application, From 2019-2024 ( USD Billion )
  41. Asia Pacific Anti-Sedatives  Market By Region, From 2019-2024 ( USD Billion )
  42. Asia Pacific Others Market By Region, From 2019-2024 ( USD Billion )
  43. Asia Pacific Atipamezole  Market By Route of Administration , From 2019-2024 ( USD Billion )
  44. Asia Pacific Intramuscular Market By Region, From 2019-2024 ( USD Billion )
  45. Asia Pacific Intravenous Market By Region, From 2019-2024 ( USD Billion )
  46. Asia Pacific Subcutaneous  Market By Region, From 2019-2024 ( USD Billion )
  47. Asia Pacific Intraperitoneal Market By Region, From 2019-2024 ( USD Billion )
  48. Japan Atipamezole  Market By Application, From 2019-2024 ( USD Billion )
  49. Japan Atipamezole  Market By Route of Administration , From 2019-2024 ( USD Billion )
  50. China Atipamezole  Market By Application, From 2019-2024 ( USD Billion )
  51. China Atipamezole  Market By Route of Administration , From 2019-2024 ( USD Billion )
  52. India Atipamezole  Market By Application, From 2019-2024 ( USD Billion )
  53. India Atipamezole  Market By Route of Administration , From 2019-2024 ( USD Billion )
  54. Australia Atipamezole  Market By Application, From 2019-2024 ( USD Billion )
  55. Australia Atipamezole  Market By Route of Administration , From 2019-2024 ( USD Billion )
  56. South Korea Atipamezole  Market By Application, From 2019-2024 ( USD Billion )
  57. South Korea Atipamezole  Market By Route of Administration , From 2019-2024 ( USD Billion )
  58. Latin America Atipamezole  Market By Application, From 2019-2024 ( USD Billion )
  59. Latin America Anti-Sedatives  Market By Region, From 2019-2024 ( USD Billion )
  60. Latin America Others Market By Region, From 2019-2024 ( USD Billion )
  61. Latin America Atipamezole  Market By Route of Administration , From 2019-2024 ( USD Billion )
  62. Latin America Intramuscular Market By Region, From 2019-2024 ( USD Billion )
  63. Latin America Intravenous Market By Region, From 2019-2024 ( USD Billion )
  64. Latin America Subcutaneous  Market By Region, From 2019-2024 ( USD Billion )
  65. Latin America Intraperitoneal Market By Region, From 2019-2024 ( USD Billion )
  66. Brazil Atipamezole  Market By Application, From 2019-2024 ( USD Billion )
  67. Brazil Atipamezole  Market By Route of Administration , From 2019-2024 ( USD Billion )
  68. Argentina Atipamezole  Market By Application, From 2019-2024 ( USD Billion )
  69. Argentina Atipamezole  Market By Route of Administration , From 2019-2024 ( USD Billion )
  70. Mexico Atipamezole  Market By Application, From 2019-2024 ( USD Billion )
  71. Mexico Atipamezole  Market By Route of Administration , From 2019-2024 ( USD Billion )
  72. Rest of Latin America Atipamezole  Market By Application, From 2019-2024 ( USD Billion )
  73. Rest of Latin America Atipamezole  Market By Route of Administration , From 2019-2024 ( USD Billion )
  74. Middle East and Africa Atipamezole  Market By Application, From 2019-2024 ( USD Billion )
  75. Middle East and Africa Anti-Sedatives  Market By Region, From 2019-2024 ( USD Billion )
  76. Middle East and Africa Others Market By Region, From 2019-2024 ( USD Billion )
  77. Middle East and Africa Atipamezole  Market By Route of Administration , From 2019-2024 ( USD Billion )
  78. Middle East and Africa Intramuscular Market By Region, From 2019-2024 ( USD Billion )
  79. Middle East and Africa Intravenous Market By Region, From 2019-2024 ( USD Billion )
  80. Middle East and Africa Subcutaneous  Market By Region, From 2019-2024 ( USD Billion )
  81. Middle East and Africa Intraperitoneal Market By Region, From 2019-2024 ( USD Billion )
  82. Middle East Atipamezole  Market By Application, From 2019-2024 ( USD Billion )
  83. Middle East Atipamezole  Market By Route of Administration , From 2019-2024 ( USD Billion )
  84. Africa Atipamezole  Market By Application, From 2019-2024 ( USD Billion )
  85. Africa Atipamezole  Market By Route of Administration , From 2019-2024 ( USD Billion )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample